RU2762279C2 - Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы - Google Patents

Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы Download PDF

Info

Publication number
RU2762279C2
RU2762279C2 RU2019121006A RU2019121006A RU2762279C2 RU 2762279 C2 RU2762279 C2 RU 2762279C2 RU 2019121006 A RU2019121006 A RU 2019121006A RU 2019121006 A RU2019121006 A RU 2019121006A RU 2762279 C2 RU2762279 C2 RU 2762279C2
Authority
RU
Russia
Prior art keywords
tetrahydropyran
ethyl
pyrazolo
dihydro
oxospiro
Prior art date
Application number
RU2019121006A
Other languages
English (en)
Russian (ru)
Other versions
RU2019121006A3 (cg-RX-API-DMAC7.html
RU2019121006A (ru
Inventor
Сифу ЛЯН
Йенс ЛАРСЕН
Симон Фельдбек НИЛЬСЕН
Петер АНДЕРСЕН
Original Assignee
Юнион Терапьютикс А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнион Терапьютикс А/С filed Critical Юнион Терапьютикс А/С
Publication of RU2019121006A3 publication Critical patent/RU2019121006A3/ru
Publication of RU2019121006A publication Critical patent/RU2019121006A/ru
Application granted granted Critical
Publication of RU2762279C2 publication Critical patent/RU2762279C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RU2019121006A 2016-12-12 2016-12-12 Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы RU2762279C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2016/080548 WO2018108230A1 (en) 2016-12-12 2016-12-12 Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors

Publications (3)

Publication Number Publication Date
RU2019121006A3 RU2019121006A3 (cg-RX-API-DMAC7.html) 2021-01-12
RU2019121006A RU2019121006A (ru) 2021-01-12
RU2762279C2 true RU2762279C2 (ru) 2021-12-17

Family

ID=57539258

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019121006A RU2762279C2 (ru) 2016-12-12 2016-12-12 Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы

Country Status (8)

Country Link
US (1) US10906915B2 (cg-RX-API-DMAC7.html)
EP (1) EP3551633B1 (cg-RX-API-DMAC7.html)
JP (1) JP6850886B2 (cg-RX-API-DMAC7.html)
CN (1) CN110088108B (cg-RX-API-DMAC7.html)
DK (1) DK3551633T3 (cg-RX-API-DMAC7.html)
ES (1) ES2875128T3 (cg-RX-API-DMAC7.html)
RU (1) RU2762279C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018108230A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11065257B2 (en) * 2016-12-12 2021-07-20 Leo Pharma A/S Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors
AU2018286964B2 (en) 2017-06-20 2022-04-14 UNION therapeutics A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
WO2019115776A1 (en) 2017-12-15 2019-06-20 Leo Pharma A/S Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005071B1 (ru) * 2000-01-05 2004-10-28 Уорнер-Ламберт Компани ЗАМЕЩЕННЫЕ ПИРАЗОЛО[4,3-e]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ
WO2007040435A1 (en) * 2005-10-03 2007-04-12 Astrazeneca Ab Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease.
WO2008104175A2 (en) * 2007-02-28 2008-09-04 Leo Pharma A/S Novel phosphodiesterase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7423031B2 (en) 2003-05-01 2008-09-09 Irm Llc Compounds and compositions as protein kinase inhibitors
CA2669886A1 (en) 2006-11-15 2008-05-22 Vertex Pharmaceuticals Incorporated Compounds useful as protein kinase inhibitors
GB0704652D0 (en) 2007-03-09 2007-04-18 Syngenta Participations Ag Novel herbicides
AR084070A1 (es) * 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005071B1 (ru) * 2000-01-05 2004-10-28 Уорнер-Ламберт Компани ЗАМЕЩЕННЫЕ ПИРАЗОЛО[4,3-e]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ
WO2007040435A1 (en) * 2005-10-03 2007-04-12 Astrazeneca Ab Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease.
WO2008104175A2 (en) * 2007-02-28 2008-09-04 Leo Pharma A/S Novel phosphodiesterase inhibitors

Also Published As

Publication number Publication date
RU2019121006A3 (cg-RX-API-DMAC7.html) 2021-01-12
DK3551633T3 (da) 2021-06-28
US10906915B2 (en) 2021-02-02
ES2875128T3 (es) 2021-11-08
US20200010477A1 (en) 2020-01-09
JP6850886B2 (ja) 2021-03-31
EP3551633A1 (en) 2019-10-16
CN110088108B (zh) 2024-06-14
JP2020500920A (ja) 2020-01-16
EP3551633B1 (en) 2021-03-31
WO2018108230A1 (en) 2018-06-21
CN110088108A (zh) 2019-08-02
RU2019121006A (ru) 2021-01-12

Similar Documents

Publication Publication Date Title
RU2583787C2 (ru) Гетероциклические соединения бензодиоксола или бензодиоксепина в качестве ингибиторов фосфодиэстераз
JP7198820B2 (ja) 置換アゼチジンジヒドロチエノピリミジンおよびホスホジエステラーゼ阻害剤としてのそれらの使用
JP7201688B2 (ja) 置換テトラヒドロピランジヒドロチエノピリミジンおよびホスホジエステラーゼ阻害剤としてのそれらの使用
CA2931732A1 (en) Substituted benzamides and methods of use thereof
EP3724196B9 (en) Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
CN111108109A (zh) 取代的二氢噻吩并嘧啶及其作为磷酸二酯酶抑制剂的用途
JP6850886B2 (ja) 置換ピラゾロアゼピン−4−オンおよびそれらのホスホジエステラーゼ阻害剤としての使用
CN104011048B (zh) 作为磷酸二酯酶抑制剂的[1,2,4]三唑并吡啶类化合物及其应用
JP7008073B2 (ja) 置換ピラゾロアゼピン-4-オンおよびそれらのホスホジエステラーゼ阻害剤としての使用
RU2764273C2 (ru) Замещенные пиразолоазепин-8-оны и их применение в качестве ингибиторов фосфодиэстеразы
HK40041147B (en) Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
HK40041147A (en) Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
HK40039957B (en) Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors

Legal Events

Date Code Title Description
HZ9A Changing address for correspondence with an applicant